Aplastic Anemia and Transplant with Richard Childs, MD

Rear Admiral (RADM) Richard Childs, MD, is the Scientific Director of the National Heart, Lung, and Blood Institute (NHLBI) at the NIH. He graduated from Georgetown University and Georgetown University Medical School and completed his medical training, including fellowships in Medical Oncology and Hematology, at the NIH.

As a tenured investigator at NHLBI, Dr. Childs focuses his research on allogeneic stem cell transplantation and tumor immunology to treat aplastic anemia, hematological malignancies, and solid tumors. His team was the first to establish the existence of a graft-vs-solid tumor effect mediated by donor T-cells, leading to cures for metastatic renal cell carcinoma. His lab discovered a novel human endogenous retrovirus (HERV-E) as a target for graft-vs-tumor effects, which induces tumor regression. They are developing T-cell based approaches to target HERV-E derived kidney cancer antigens and are investigating these in a clinical trial at the NIH Clinical Center.

Dr. Childs also focuses…